Astrazeneca Share Discussion Threads

[paa65] 08/4/2022 13:43

Amazed there is so little chatter on this board. Up 25% in a month. Keeping entire FTSE up whilst Europe and US markets fall.But no interest here? Who is buying this?

[la forge] 07/4/2022 06:37

James Gordon from JP Morgan retains his positive opinion on the stock with a Buy rating.


The target price is reviewed upwards from GBX 10000 to GBX 12000.

[misca2] 06/4/2022 16:00

Analysts at Deutsche Bank hiked their target price for AstraZeneca shares from 10,500.0p to 11,500.0p, telling clients it saw no reason to tilt towards so-called 'value' names in the space and away from 'growth'.

Deutsche Bank conceded that an environment of rising interest rates would normally hardly be seen as auguring positively for a defensive sector to outperform.

However, DB highlighted that these weren't exactly normal times.

"This being a geopolitically-challenged stagflationary-susceptible situation, normal perhaps doesn't apply and indeed pharma has had a strong relative start to the year that may well continue," explained DB.

Within the sector, more highly-valued growth names such as AstraZeneca and Novo Nordisk had been the standout outperformers, versus the likes of GlaxoSmithKline, Novartis or Sanofi.

[philanderer] 06/4/2022 09:09

Deutsche Bank raises AstraZeneca price target to 11,500 (10,500) pence - 'buy'

[chc15] 05/4/2022 15:24

As mentioned, big momentum here, institutions buying at this level, so why sell.

[dudishes] 05/4/2022 14:59

WD Waldron, good forecast!

[waldron] 05/4/2022 06:15

Todays the day it might well break thru an important Resistence level

[waldron] 05/4/2022 06:14

(MT Newswires) -- AstraZeneca (AZN.L, AZN.ST) said Monday its AZD8233 drug at 50-milligram dose lowered the levels of low-density lipoprotein cholesterol by 73% among people with high-risk hypercholesterolemia, meeting the main goal of a phase 2b study.

The dose-ranging clinical trial, dubbed Etesia, evaluated AZD8233 at 15 mg, 50 mg and 90 mg doses administered monthly via subcutaneous injection within a 12-week period.

Results showed that the drug also cut the PCSK9 enzyme levels by 89%, with sustained reductions observed over the dosing intervals. A decrease in PCSK9 raises LDL receptor levels, which in turn lowers cholesterol levels in the bloodstream, reducing the risk of developing heart disease.

The safety, efficacy and tolerability of AZD8233 in hypercholesterolemia are being examined in the Solano phase 2b trial, with results expected later in the year.

AstraZeneca gained nearly 1% on Monday's close.

Price (GBP): £10142.00, Change: £+66.00, Percent Change: +0.66%

[chc15] 31/3/2022 17:44

Mind u, mkts going down after putins demands, so taking profits not a bad thing.

[chc15] 31/3/2022 17:15

No harm in taking profits, but feel there is good momentum here.

[beckers2008] 31/3/2022 14:48

I'm out at £102. This is above quite a few broker PT's so happy to take profits.
Currently way above 20 mda, too high too quickly, will buy back when it settles.
Good Luck all.

[chc15] 31/3/2022 11:22

We surging here, can only mean there is strong institutional buying at this level, wow.

[hotfinance14] 29/3/2022 13:09

Azn holders now in the 100 club..olaay olay olay.

[holts] 29/3/2022 11:31

May 2020 I said it would exceed 100 , bit premature that was , however where is our serial doomster Buywell ? Buybadly .

[gateside] 29/3/2022 08:48

Onwards and Upwards. Let's see it can close above £100 later today.

[ygor705] 29/3/2022 08:37

Sp through the £100 level for the first time - a bit of a landmark price!

[gateside] 27/3/2022 18:39

Ianood - A split is what a meant - I got it the wrong way round!

[ianood] 27/3/2022 17:25

Gateside - I fancy a split is more likely?

[gateside] 27/3/2022 17:03

I wonder if AZN will do a share consolidation at some point?

[growthpotential] 27/3/2022 16:50

Must be hitting 10,000 soon, surely

[jimarilo] 17/3/2022 01:41

Here's one for those planning to take their next jab in the Autumn ......Do you feel lucky Punk ......????

Approved under "emergency use"...not licenced

EU medicines agency recommends approval of Moderna’s COVID-19 vaccine for children age 6-11
Spikevax vaccine is already approved for use in adults and children age 12 and over

Seda Sevencan |
25.02.2022




and yet from the uk govt........

Myocarditis and pericarditis
There is an increased risk for myocarditis and pericarditis following vaccination with Spikevax. These conditions can develop within just a few days after vaccination, and have primarily occurred within 14 days. They have been observed more often after the second vaccination, and more often in younger males



They know the risk of myocarditis, which is an irreversible heart disease. This is 100% criminal

[riskonricky] 12/3/2022 22:06

What a load of trash

[badger60] 12/3/2022 21:26

Pfizer hidden covid vaxx data released.